Osteopathy in mild adrenal Cushing's syndrome and Cushing disease.
adrenal incidentaloma
bone mineral density
bone quality
cushing disease
fractures
glucocorticoids
Journal
Best practice & research. Clinical endocrinology & metabolism
ISSN: 1878-1594
Titre abrégé: Best Pract Res Clin Endocrinol Metab
Pays: Netherlands
ID NLM: 101120682
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
3
4
2021
medline:
21
9
2021
entrez:
2
4
2021
Statut:
ppublish
Résumé
Pathophysiology and effects of endogenous glucocorticoid (GC) excess on skeletal endpoints as well as awareness and management of bone fragility are reviewed. Cushing's syndrome (CS) increase the risk of fracture affecting prevalently bone quality. Bone antiresorptive agents (SERMs, bisphosphonates and denosumab) as well as teriparatide increase bone mineral density and in some instances reduce fracture risk. Awareness and management of bone health in CS can be improved.
Identifiants
pubmed: 33795196
pii: S1521-690X(21)00032-4
doi: 10.1016/j.beem.2021.101515
pii:
doi:
Substances chimiques
Bone Density Conservation Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101515Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.